TRT claims on TikTok: separating protocol facts from hype

What did @nickkomodina_official actually say?

He said it plainly: "it is 100% easier to build muscle, lose fat, stay in shape" on some form of PED, even if that's just TRT doses. After eight years on exogenous testosterone, starting at age 24, he went four weeks fully off and noticed real differences in strength retention, dietary tolerance, and muscle fullness. He also walked back a position he used to hold, admitting he previously downplayed how much easier anabolics made training. That kind of self-correction is worth acknowledging. He is not telling anyone to use PEDs. He is describing what he personally observed when he stopped.

The claim that matters clinically is this: supraphysiologic or even low-dose exogenous testosterone provides a meaningful anabolic advantage that becomes obvious only when you remove it. That is the core assertion, and it is testable.

Does the science back this up?

Yes, substantially. The evidence that exogenous testosterone increases muscle protein synthesis, lean mass, and strength beyond what natural training produces is not seriously disputed in the literature.

Bhasin et al. (1996, New England Journal of Medicine) showed that testosterone enanthate at 600 mg per week produced significant gains in fat-free mass and muscle size even without exercise, compared to placebo with exercise. The men on testosterone who also trained gained the most, but the hormone alone outperformed drug-free training alone. That study is now nearly 30 years old and its findings have held up.

More relevant to his specific claim about withdrawal, Storer et al. (2003, American Journal of Physiology) documented that testosterone dose-dependently increases muscle strength and power, with clear dose-response relationships. When levels drop, those advantages attenuate. There is also a body of evidence on hypogonadism and muscle function showing that men with low testosterone have measurably reduced lean mass and strength compared to eugonadal men, reinforcing the idea that testosterone level matters even within normal ranges.

His subjective report of flatter muscles is consistent with reduced glycogen retention and intramuscular water that accompanies lower androgen levels. This is real physiology, not placebo.

What did they get wrong (or right)?

He got the core physiology right. What he got partially wrong, or at least incomplete, is framing eight years of continuous exogenous testosterone use as a straightforward comparison point.

He has been suppressing his hypothalamic-pituitary-gonadal axis since age 24. After eight continuous years, his endogenous testosterone production is almost certainly significantly blunted, and four weeks off is nowhere near long enough for the HPG axis to recover. Rahnema et al. (2014, Fertility and Sterility) documented that post-anabolic steroid hypogonadism can persist for years after cessation, not weeks. So when he says he feels weaker and flatter after 30 days, he may not be comparing himself to a natural baseline. He may be comparing supraphysiologic function to a temporarily hypogonadal state.

That does not make his observation wrong, but it changes what the observation means. He is not experiencing what a lifelong natural athlete experiences. He is experiencing withdrawal from eight years of HPG suppression. Those are different things, and conflating them slightly overstates the universal applicability of his point.

He deserves credit for admitting he was wrong about effort equivalence. That kind of honest self-correction is rare in fitness content.

What should you actually know?

If you are considering TRT through a legitimate medical channel, this video is not a clinical guide. Testosterone therapy prescribed for diagnosed hypogonadism, meaning clinically low levels confirmed by bloodwork and symptoms, is a different category from self-administered PED use starting at age 24 on a competitive physique circuit. The two are frequently conflated online, and that conflation causes real harm.

Legitimate TRT is typically dosed to restore physiologic testosterone levels, not to exceed them. The performance advantages he describes are largely associated with supraphysiologic dosing, not replacement dosing. A man going from 250 ng/dL to 600 ng/dL on TRT will feel better and may retain muscle more easily. A competitive physique athlete running 150 mg testosterone weekly as a minimum is operating in a different hormonal range than most TRT patients.

His mention of elevated blood pressure and oxidative stress from higher-dose cycles at age 24 is clinically significant and consistent with the cardiovascular risk literature. Baggish et al. (2017, Circulation) found that long-term anabolic steroid use is associated with cardiomyopathy, reduced left ventricular function, and increased cardiovascular mortality risk. That context is missing from his video and it matters.

If your testosterone is genuinely low, talk to a physician. If you are considering exogenous hormones for performance, understand that the downstream costs, including prolonged HPG suppression, cardiovascular strain, and fertility effects, are real and documented.